Clinical Trials Browser

Phase 1/2 × Leukemia × Dasatinib × Clear all

Leukemia, Recurrence, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00829647 2019-04-11

A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia

Phase 1/2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01218477 2016-06-17

Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)

Phase 1/2 Completed

33 enrolled 18 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Chronic-Phase

Clinical Trials

HEM-iSMART B

A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia

Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)